How have HSCS shares performed in 2024?

Heart Test Laboratories' stock was trading at $0.1710 at the beginning of 2024. Since then, HSCS stock has decreased by 41.5% and is now trading at $0.1001. View the best growth stocks for 2024 here .

Are investors shorting Heart Test Laboratories?

Heart Test Laboratories saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 135,300 shares, a drop of 73.3% from the March 15th total of 506,000 shares. Based on an average daily volume of 2,700,000 shares, the short-interest ratio is presently 0.1 days. Currently, 0.3% of the shares of the company are short sold. View Heart Test Laboratories' Short Interest .

When is Heart Test Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024. View our HSCS earnings forecast .

How were Heart Test Laboratories' earnings last quarter?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) released its quarterly earnings results on Thursday, March, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business earned $0.02 million during the quarter.

When did Heart Test Laboratories IPO?

Heart Test Laboratories (HSCS) raised $9 million in an initial public offering on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.

How do I buy shares of Heart Test Laboratories?

Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HSCS

Heart Test Laboratories (HSCS) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free HSCS Stock Alerts

$0.10

-0.01 (-7.74%)

(As of 05:37 PM ET)

Compare

Today's Range: $0.10
▼
$0.11
50-Day Range: $0.10
▼
$0.18
52-Week Range: $0.09
▼
$1.32

Volume: 1.14 million shs
Average Volume: 2.49 million shs
Market Capitalization: $6.56 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Heart Test Laboratories alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Heart Test Laboratories Stock (NASDAQ:HSCS)

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HSCS Stock News Headlines

April 13, 2024 | msn.com

Roche Diagnostics India launches heart failure test for diabetics in India

April 4, 2024 | msn.com

Early coronary disease, impaired heart function found in asymptomatic people with HIV

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

April 4, 2024 | msn.com

The Importance of Regular Lipid Profile Testing For Cardiovascular Wellness

April 2, 2024 | globenewswire.com

HeartSciences to Present at the LD Micro Invitational XIV Conference

March 26, 2024 | globenewswire.com

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

March 15, 2024 | finanznachrichten.de

Heart Test Laboratories, Inc.: HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 14, 2024 | benzinga.com

Recap: Heart Test Laboratories Q3 Earnings

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

March 14, 2024 | finance.yahoo.com

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 14, 2024 | globenewswire.com

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 12, 2024 | morningstar.com

Heart Test Laboratories Inc

March 12, 2024 | finance.yahoo.com

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

March 12, 2024 | globenewswire.com

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

March 6, 2024 | investorplace.com

Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today?

March 6, 2024 | globenewswire.com

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

February 26, 2024 | globenewswire.com

HeartSciences Adds Key Advisor to its Scientific Advisory Board

February 24, 2024 | forbes.com

Best At-Home Blood Tests: A 2024 Guide

February 12, 2024 | finance.yahoo.com

HeartSciences Expands its Scientific Advisory Board

February 2, 2024 | msn.com

'Heart-on-a-chip' to test chemotherapies and other cancer drugs for heart toxicity

February 1, 2024 | msn.com

Promising heart drugs identified by cutting-edge combo of machine learning, human learning

December 20, 2023 | investing.com

Heart Test Laboratories Unt (HSCS) Earnings Dates & Reports

December 15, 2023 | finanznachrichten.de

Heart Test Laboratories, Inc.: HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

November 21, 2023 | benzinga.com

Thinking about buying stock in Devon Energy, NextEra Energy, Datadog, Heart Test Laboratories, or Artivion?

November 20, 2023 | finance.yahoo.com

HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

October 19, 2023 | finance.yahoo.com

HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments

September 25, 2023 | finance.yahoo.com

HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.

See More Headlines

Receive HSCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2024
Today: 4/19/2024
Fiscal Year End: 4/30/2024
Next Earnings (Estimated): 7/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:HSCS
CUSIP: N/A
CIK: 1468492
Web: heartsciences.com
Phone: 682-237-7781
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.48)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,350,000.00
Net Margins: N/A
Pretax Margin: -33,636.84%
Return on Equity: -381.92%
Return on Assets: -134.17%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.09
Quick Ratio: 4.70

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.02 per share
Price / Book: 5.34

Miscellaneous

Outstanding Shares: 65,560,000
Free Float: 63,779,000
Market Cap: $7.00 million
Optionable: Not Optionable
Beta: 3.44

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Andrew Simpson (Age 54)
CEO, President & Chairman of the Board of Directors
Comp: $264.14k
Ms. Danielle Watson (Age 41)
CFO & Treasurer
Comp: $188.75k
Mr. Mark T. Hilz (Age 65)
COO, Secretary & Director
Comp: $263.61k

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HSCS Stock Analysis - Frequently Asked Questions

How have HSCS shares performed in 2024?: Heart Test Laboratories' stock was trading at $0.1710 at the beginning of 2024. Since then, HSCS stock has decreased by 41.5% and is now trading at $0.1001.
View the best growth stocks for 2024 here.
Are investors shorting Heart Test Laboratories?: Heart Test Laboratories saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 135,300 shares, a drop of 73.3% from the March 15th total of 506,000 shares. Based on an average daily volume of 2,700,000 shares, the short-interest ratio is presently 0.1 days. Currently, 0.3% of the shares of the company are short sold.
View Heart Test Laboratories' Short Interest.
When is Heart Test Laboratories' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024.
View our HSCS earnings forecast.
How were Heart Test Laboratories' earnings last quarter?: Heart Test Laboratories, Inc. (NASDAQ:HSCS) released its quarterly earnings results on Thursday, March, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business earned $0.02 million during the quarter.

When did Heart Test Laboratories IPO?: Heart Test Laboratories (HSCS) raised $9 million in an initial public offering on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.
How do I buy shares of Heart Test Laboratories?: Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSCS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Heart Test Laboratories (HSCS) Stock Price, News & Analysis

About Heart Test Laboratories Stock (NASDAQ:HSCS)

HSCS Stock Price History

HSCS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

HSCS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info